Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MRg-NIRS Imaging System Breast Cancer Trial

NCT: NCT06400563 · RECRUITING

NCT IDNCT06400563
StatusRECRUITING
Start Date2024-11-25
Completion2034-07-01
SponsorKeith D. Paulsen (OTHER)
First posted
Last updated

Brief Summary

This trial is a study of 20 women with breast cancer to evaluate the addition of MR-guided (MRg) near-infrared spectroscopy (NIRS) with and without contrast, as part of a program to improve clinical management of women receiving breast magnetic resonance imaging (MRI).

Frequently Asked Questions

What is MRg-NIRS Imaging System Breast Cancer Trial?

MRg-NIRS Imaging System Breast Cancer Trial is a clinical trial registered under NCT06400563. Current status: RECRUITING.

What is the status of NCT06400563?

The current status of NCT06400563 (MRg-NIRS Imaging System Breast Cancer Trial) is: RECRUITING.

When did MRg-NIRS Imaging System Breast Cancer Trial start?

MRg-NIRS Imaging System Breast Cancer Trial started on 2024-11-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑